HK1009154A1 - Neural transplantation using pluripotent neuroepithelial cells - Google Patents
Neural transplantation using pluripotent neuroepithelial cellsInfo
- Publication number
- HK1009154A1 HK1009154A1 HK98110007A HK98110007A HK1009154A1 HK 1009154 A1 HK1009154 A1 HK 1009154A1 HK 98110007 A HK98110007 A HK 98110007A HK 98110007 A HK98110007 A HK 98110007A HK 1009154 A1 HK1009154 A1 HK 1009154A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- neuroepithelial cells
- pluripotent neuroepithelial
- neural transplantation
- cells
- pluripotent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518606.0A GB9518606D0 (en) | 1995-09-12 | 1995-09-12 | Neural transplantation |
PCT/GB1996/002251 WO1997010329A1 (en) | 1995-09-12 | 1996-09-12 | Neural transplantation using pluripotent neuroepithelial cells |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1009154A1 true HK1009154A1 (en) | 1999-05-28 |
Family
ID=10780583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98110007A HK1009154A1 (en) | 1995-09-12 | 1998-08-19 | Neural transplantation using pluripotent neuroepithelial cells |
Country Status (21)
Country | Link |
---|---|
US (3) | US7048921B2 (hu) |
EP (1) | EP0850298B1 (hu) |
JP (1) | JP4280872B2 (hu) |
KR (1) | KR19990044606A (hu) |
CN (1) | CN1193345A (hu) |
AT (1) | ATE242316T1 (hu) |
AU (1) | AU711563B2 (hu) |
CA (1) | CA2231436C (hu) |
CZ (1) | CZ296669B6 (hu) |
DE (1) | DE69628566T2 (hu) |
DK (1) | DK0850298T3 (hu) |
ES (1) | ES2196172T3 (hu) |
GB (1) | GB9518606D0 (hu) |
HK (1) | HK1009154A1 (hu) |
HU (1) | HUP9802091A3 (hu) |
NO (1) | NO981072L (hu) |
PL (1) | PL186777B1 (hu) |
PT (1) | PT850298E (hu) |
RU (1) | RU2185833C2 (hu) |
SK (1) | SK285816B6 (hu) |
WO (1) | WO1997010329A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014400A1 (en) | 1994-11-08 | 1996-05-17 | Bradley Michael John Stringer | Human cell-lines |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) * | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
KR100801764B1 (ko) * | 1999-09-17 | 2008-02-05 | 레뉴런 리미티드 | 세포의 조건부 불멸화 |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
DE602005002430T2 (de) | 2004-09-30 | 2008-06-19 | Reneuron Ltd., Guildford | Zelllinie |
CN101772580B (zh) * | 2007-05-29 | 2015-11-25 | 克里斯多佛·B·里德 | 专能细胞群的生产和使用方法 |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
US20150232662A1 (en) * | 2014-02-20 | 2015-08-20 | Sabic Innovative Plastics Ip B.V. | Thermoplastic composition and article |
US20170173114A1 (en) * | 2014-05-07 | 2017-06-22 | Joslin Diabetes Center, Inc. | Methods and compositions for induction of ucp1 expression |
CN116590345B (zh) * | 2023-05-06 | 2024-01-30 | 北京中医药大学 | 永生化小鼠足细胞系及其制备方法、分化方法和应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US28510A (en) * | 1860-05-29 | John e | ||
US203483A (en) * | 1878-05-07 | Improvement in honey-boxes | ||
US146821A (en) * | 1874-01-27 | Improvement in nose-pieces of nail-plate feeders | ||
US1662A (en) * | 1840-06-27 | ariel nobris | ||
US147873A (en) * | 1874-02-24 | Improvement in nasal yokes for animals | ||
US913443A (en) * | 1908-08-13 | 1909-02-23 | Webster Full Expansion Rotary Engine Company | Rotary engine. |
NZ226750A (en) * | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
US5270191A (en) | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
JPH03504799A (ja) | 1988-04-12 | 1991-10-24 | マサチューセッツ・インスティチュート・オブ・テクノロジー | 真核細胞の細胞型を操作する方法 |
US5070191A (en) * | 1989-04-27 | 1991-12-03 | Ajinomoto Co., Inc. | Demethylallosamidin and a process for production thereof |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
WO1991009936A1 (en) * | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
US5612211A (en) | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
RU2028089C1 (ru) * | 1990-10-16 | 1995-02-09 | Украинский научно-исследовательский институт нейрохирургии | Способ лечения апаллического синдрома |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
CA2113118C (en) * | 1991-07-08 | 2002-09-17 | Samuel Weiss | Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
KR950700403A (ko) | 1992-03-04 | 1995-01-16 | 죤 제이. 쉬바르츠 | 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) |
EP0696205B1 (en) | 1993-04-13 | 2002-01-23 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS | Use of neuro-derived fetal cell lines for transplantation therapy |
US5753491A (en) | 1993-04-13 | 1998-05-19 | Us Health | Use of neuro-derived fetal cell lines for transplantation therapy |
WO1996014400A1 (en) | 1994-11-08 | 1996-05-17 | Bradley Michael John Stringer | Human cell-lines |
JPH10509592A (ja) * | 1994-11-14 | 1998-09-22 | ニューロスフィアーズ ホウルディングス リミテッド | 神経幹細胞増殖調節 |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517263D0 (en) * | 1995-08-23 | 1995-10-25 | Cancer Res Campaign Tech | Expression systems |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5588692A (en) * | 1995-10-11 | 1996-12-31 | General Motors Corporation | Push-out vehicle side door |
WO1998007841A1 (en) | 1996-08-19 | 1998-02-26 | University Of Massachusetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
SE9604322D0 (sv) * | 1996-11-25 | 1996-11-25 | Astra Ab | Bacterial antigens and vaccine compositions II |
US20020123143A1 (en) | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
ES2246085T3 (es) * | 1998-05-07 | 2006-02-01 | University Of South Florida | Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro. |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) * | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
WO2001066698A1 (en) | 2000-03-09 | 2001-09-13 | Cryo-Cell International, Inc. | Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
US7049072B2 (en) * | 2000-06-05 | 2006-05-23 | University Of South Florida | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
WO2001094541A2 (en) | 2000-06-05 | 2001-12-13 | University Of South Florida | Human mesenchymal progenitor cell |
WO2003029432A2 (en) | 2001-10-03 | 2003-04-10 | University Of South Florida | Human mesenchymal progenitor cell |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
DE602005002430T2 (de) * | 2004-09-30 | 2008-06-19 | Reneuron Ltd., Guildford | Zelllinie |
-
1995
- 1995-09-12 GB GBGB9518606.0A patent/GB9518606D0/en active Pending
-
1996
- 1996-09-12 AU AU69375/96A patent/AU711563B2/en not_active Expired
- 1996-09-12 DK DK96930260T patent/DK0850298T3/da active
- 1996-09-12 KR KR1019980701856A patent/KR19990044606A/ko not_active Application Discontinuation
- 1996-09-12 PT PT96930260T patent/PT850298E/pt unknown
- 1996-09-12 EP EP96930260A patent/EP0850298B1/en not_active Expired - Lifetime
- 1996-09-12 RU RU98107327/14A patent/RU2185833C2/ru not_active IP Right Cessation
- 1996-09-12 CA CA002231436A patent/CA2231436C/en not_active Expired - Lifetime
- 1996-09-12 WO PCT/GB1996/002251 patent/WO1997010329A1/en active IP Right Grant
- 1996-09-12 SK SK306-98A patent/SK285816B6/sk unknown
- 1996-09-12 PL PL96325646A patent/PL186777B1/pl unknown
- 1996-09-12 JP JP51175697A patent/JP4280872B2/ja not_active Expired - Lifetime
- 1996-09-12 CZ CZ0055898A patent/CZ296669B6/cs not_active IP Right Cessation
- 1996-09-12 HU HU9802091A patent/HUP9802091A3/hu unknown
- 1996-09-12 DE DE69628566T patent/DE69628566T2/de not_active Expired - Lifetime
- 1996-09-12 CN CN96196376A patent/CN1193345A/zh active Pending
- 1996-09-12 ES ES96930260T patent/ES2196172T3/es not_active Expired - Lifetime
- 1996-09-12 AT AT96930260T patent/ATE242316T1/de not_active IP Right Cessation
-
1998
- 1998-03-11 NO NO981072A patent/NO981072L/no not_active Application Discontinuation
- 1998-08-19 HK HK98110007A patent/HK1009154A1/xx not_active IP Right Cessation
-
2001
- 2001-01-12 US US09/760,274 patent/US7048921B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/376,119 patent/US20030147873A1/en not_active Abandoned
-
2005
- 2005-07-08 US US11/178,216 patent/US7371374B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU6937596A (en) | 1997-04-01 |
US20030147873A1 (en) | 2003-08-07 |
CA2231436C (en) | 2007-07-17 |
PL186777B1 (pl) | 2004-02-27 |
US7048921B2 (en) | 2006-05-23 |
HUP9802091A2 (hu) | 1998-12-28 |
ATE242316T1 (de) | 2003-06-15 |
US20060051326A1 (en) | 2006-03-09 |
EP0850298B1 (en) | 2003-06-04 |
US7371374B2 (en) | 2008-05-13 |
NO981072D0 (no) | 1998-03-11 |
DE69628566T2 (de) | 2004-05-06 |
RU2185833C2 (ru) | 2002-07-27 |
GB9518606D0 (en) | 1995-11-15 |
CN1193345A (zh) | 1998-09-16 |
ES2196172T3 (es) | 2003-12-16 |
DE69628566D1 (de) | 2003-07-10 |
HUP9802091A3 (en) | 2001-01-29 |
JP4280872B2 (ja) | 2009-06-17 |
DK0850298T3 (da) | 2003-09-15 |
PT850298E (pt) | 2003-09-30 |
CZ55898A3 (cs) | 1998-06-17 |
CZ296669B6 (cs) | 2006-05-17 |
JPH11513242A (ja) | 1999-11-16 |
NO981072L (no) | 1998-05-12 |
US20010001662A1 (en) | 2001-05-24 |
SK30698A3 (en) | 1999-01-11 |
CA2231436A1 (en) | 1997-03-20 |
EP0850298A1 (en) | 1998-07-01 |
SK285816B6 (sk) | 2007-09-06 |
PL325646A1 (en) | 1998-08-03 |
KR19990044606A (ko) | 1999-06-25 |
AU711563B2 (en) | 1999-10-14 |
WO1997010329A1 (en) | 1997-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1009154A1 (en) | Neural transplantation using pluripotent neuroepithelial cells | |
WO2001036589A3 (en) | Human ex vivo immune system | |
WO1997012960A3 (en) | Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system | |
DE69609222T2 (de) | Partikel auf Polyaminosäure(n)basis zur Verwendung als Wirkstoffträger sowie deren Herstellungsverfahren | |
IL143283A0 (en) | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells | |
IL121790A0 (en) | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (GDNF) protein product | |
MX340738B (es) | Terapia para deficiencia de a-galactosidasa a. | |
GB9308271D0 (en) | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method | |
HUT64595A (en) | Method for producing mammalian cytokine, il-11 | |
WO1997004097A3 (en) | Human CTLA-8 and uses of CTLA-8-related proteins | |
MY113045A (en) | Waste treatment plant and process | |
GR3005297T3 (hu) | ||
MX9702126A (es) | Modelos in vitro de funcion y disfuncion del snc. | |
ES8403157A1 (es) | Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral. | |
DE69637709D1 (de) | Durch elektroporation vermittelter molekulartransfer in intakten pflanzen | |
WO1999029279A3 (en) | Long-term survival and regeneration of central nervous system neurons | |
IL90414A (en) | Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals | |
AU5391886A (en) | Method and device for the in vitro culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants | |
PL310950A1 (en) | Novel imidazole quinoxalinones, method of obtaining them and their application | |
AU7577091A (en) | Process for the artificial stimulation of cells and cyte culture device | |
EP0723454A4 (en) | NEW TRIPEPTIDES FOR THE TREATMENT OF THE IMMUNE SYSTEM AND THE CNS | |
WO2003040304A3 (en) | Method of proliferation in neurogenic regions | |
EP0142109A3 (en) | Macromolecules extracted from cultured mesenchymal cells for the treatment of degenerative diseases | |
ATA15189A (de) | Humaner monoklonaler antikoerper, verfahren zu dessen herstellung, arzneimittel und hybridzelle | |
ATE317905T1 (de) | Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20160911 |